Kidney shield showdown: mannitol vs nitroglycerin in robotic surgery
NCT ID NCT06408597
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study compares two drugs, mannitol and nitroglycerin, given during robotic prostate or bladder cancer surgery to see if they can prevent acute kidney injury. The surgery uses gas to inflate the belly, which can reduce blood flow to the kidneys. The trial includes 90 adults with normal or mildly reduced kidney function. The goal is to find which drug better protects kidney health after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University Hospitals
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.